Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng Ya Hsu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Anticancer Research|January 30, 2026
Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional ValidationJipu Liu, Cheng Ya Hsu, Jianming Lu, et al.
World Journal of Surgical Oncology|April 14, 2026
MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic responseSiqiao Peng, Yu Liu, Peisheng Huang, et al.
Journal of Clinical & Translational Endocrinology|July 21, 2025
Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinomaJiahong Chen, Peisheng Huang, Yongcheng Shi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Anticancer Research|January 30, 2026
Prognostic Significance of PPFIA2 in Localized Prostate Cancer: Integrative Analysis and Functional ValidationJipu Liu, Cheng Ya Hsu, Jianming Lu, et al.
World Journal of Surgical Oncology|April 14, 2026
MTHFD1L in muscle invasive bladder cancer: a multi-cohort study on prognosis and therapeutic responseSiqiao Peng, Yu Liu, Peisheng Huang, et al.
Journal of Clinical & Translational Endocrinology|July 21, 2025
Cell division cycle 20 promotes tumor progression and predicts poor clinical outcome in childhood and adult adrenocortical carcinomaJiahong Chen, Peisheng Huang, Yongcheng Shi, et al.
Pageof 1